AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
250.91
+2.13 (0.86%)
At close: Sep 9, 2026, 4:00 PM EDT
250.75
-0.16 (-0.06%)
After-hours: Sep 9, 2026, 7:59 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $276.59. The average 1-year stock price forecast is 10.23% higher than the current stock price, while the lowest is $200 (-20.29%) and the highest is $328 (+30.72%).
Price Target: $276.59 (+10.23%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 16 | 17 | 17 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 8 | 8 | 6 | 6 | 5 | 5 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 32 | 32 | 31 | 31 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $276 → $282 | Buy | Reiterates | $276 → $282 | +12.39% | Sep 8, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $280 | Buy | Reiterates | $280 | +11.59% | Sep 4, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $300 | Buy | Maintains | $300 | +19.56% | Sep 4, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $280 | Buy | Maintains | $280 | +11.59% | Sep 4, 2026 |
| Citi | Citi | Hold Maintains $260 | Hold | Maintains | $260 | +3.62% | Sep 4, 2026 |
Financial Forecast
Revenue This Year
67.58B
from 61.16B
Increased by 10.50%
Revenue Next Year
73.52B
from 67.58B
Increased by 8.78%
EPS This Year
14.01
from 10.00
Increased by 40.11%
EPS Next Year
16.28
from 14.01
Increased by 16.19%
EPS and Forward PE are based on non-GAAP adjusted numbers.